Mundipharma

Mundipharma is a global healthcare company with over 60 years of heritage, operating across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East. The company's portfolio spans approximately 50 primary and specialty care medicines in pain management, oncology, respiratory, and infectious disease. For a cybersecurity team, that means protecting a sprawling attack surface: pharmaceutical intellectual property, clinical data pipelines, regulated patient information, and operational technology across manufacturing and distribution networks in multiple regulatory jurisdictions. The threat model here is layered. Pharma companies face nation-state interest in drug research, ransomware targeting production uptime, and strict compliance regimes around health data. Security operations need to account for endpoint protection across a globally distributed workforce, identity and access management at scale, and securing the supply chain from API integrations with healthcare providers and partners down to third-party logistics. Mundipharma describes a culture grounded in integrity, continuous learning, and collaboration - signals that suggest security is treated as a business enabler rather than a siloed cost center. The company emphasizes people-centric values and encouraging different thinking, which in practice likely means security teams work cross-functionally with R&D, commercial operations, and IT across diverse geographies. The work is protecting critical healthcare infrastructure where downtime and breaches carry real clinical consequences.